Works matching AU Xi, L.‐Y.


Results: 4
    1
    2
    3

    Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 1, p. 89, doi. 10.1111/jdv.13746
    By:
    • Cai, L.;
    • Gu, J.;
    • Zheng, J.;
    • Zheng, M.;
    • Wang, G.;
    • Xi, L. ‐ Y.;
    • Hao, F.;
    • Liu, X. ‐ M.;
    • Sun, Q. ‐ N.;
    • Wang, Y.;
    • Lai, W.;
    • Fang, H.;
    • Tu, Y. ‐ T.;
    • Sun, Q.;
    • Chen, J.;
    • Gao, X. ‐ H.;
    • Gu, Y.;
    • Teixeira, H.D.;
    • Zhang, J. ‐ Z.;
    • Okun, M.M.
    Publication type:
    Article
    4

    Aetiology of tinea capitis in China: a multicentre prospective study*.

    Published in:
    British Journal of Dermatology, 2022, v. 186, n. 4, p. 705, doi. 10.1111/bjd.20875
    By:
    • Chen, X.‐Q.;
    • Zheng, D.‐Y.;
    • Xiao, Y.‐Y.;
    • Dong, B.‐L.;
    • Cao, C.‐W.;
    • Ma, L.;
    • Tong, Z.‐S.;
    • Zhu, M.;
    • Liu, Z.‐H.;
    • Xi, L.‐Y.;
    • Fu, M.;
    • Jin, Y.;
    • Yin, B.;
    • Li, F.‐Q.;
    • Li, X.‐F.;
    • Abliz, P.;
    • Liu, H.‐F.;
    • Zhang, Y.;
    • Yu, N.;
    • Wu, W.‐W.
    Publication type:
    Article